2-D and 3-D modeling of imidazoline receptor ligands: Insights into pharmacophore

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 5, 1997, Pages 843-856

  Carrieri, A ^a   Brasili, L ^c   Leonetti, F ^a   Pigini, M ^c   Giannella, M ^c   Bousquet, P ^b   Carotti, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; IMIDAZOLINE RECEPTOR; LIGAND;

ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG CONFORMATION; DRUG RECEPTOR BINDING; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; ELECTROSTATICS; IMIDAZOLES; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030912917     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00023-0     Document Type: Article

References (37)

1. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959.
2. Cramer, R. D.; De Prierst, S. A.; Patterson, D. E.; Hect, P. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 443-485.
3. Dunn, III, W. J.; Wold, S.; Edlund, U.; Helberg, S. Quant. Struct.-Act. Relat. 1984, 3, 131.
4. Wold, S.; Johansson, E.; Cocchi, M. In 3D QSAR in Drug Design: Theory, Methods and Applications: Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 523-549.
5. Cramer, R. D.; Bunce, J. D.; Patterson, D. E. Quant. Struct.-Act. Relat. 1988, 7, 18.
6. Pigini, M.; Bousquet, P.; Carotti, A.; Dontewill, M.; Giannella, M.; Moriconi, R.; Piergentili, A.; Quaglia, W.; Tayebati, K. S.; Brasili, L. Bioorg. Med. Chem., this issue.
7. Trumpp-Kallmeyer, S.; Hoflack, J.; Bruinvels, A.; Hibert, M. J. Med. Chem. 1992, 35, 3448.
8. Ruffolo, Jr, R. R.; Nichols, A. J.; Stadel, J. M.; Hieble, J. T. Pharmacol. Rev. 1991, 43, 475.
9. Rouvinen, J.; Hoffren, A.; Karjalainen, A.; Tapani, A. P. Drug Des. Disc. 1993, 10, 285.
10. Kubinyi, H. QSAR: Hansch Analysis and Related Approaches; VHC; Weinheim, 1993.
11. Hansch, C.; Leo, A.; Hoeckman, D. Exploring QSAR; ACS:Washington, 1995; Vols 1 and 2.
12. Kneubühler, S.; Thull, U.; Altomare, C.; Carta, V.; Gaillard, P.; Carrupt, P.-A.; Carotti, A.; Testa, B. J. Med. Chem. 1995, 38, 3874.
13. Carrieri, A.; Altomare, C.; Barreca, M. L.; Contento, A.; Carotti, A.; Hansen, C. Il Farmaco 1994, 49, 573.
14. Carotti, A.; Raguseo, C.; Campagna, F.; Langridge, R.; Klein, T. E. Quant. Struct.-Act. Rel. 1989, 8, 1.
15. Altomare, C.; Carotti, A.; Cellamare, S.; Carrupt, P.-A.; Testa, B. Chirality 1993, 5, 527.
16. Carotti, A.; Altomare, C.; Cellamare, S.; Monforte, A. M.; Bettoni, G.; Loiodice, F.; Tangari, N.; Tortorella, V. J. Comp.-Aided Mol. Des. 1995, 9, 131.
17. Hansch, C.; Leo, A. In Substituent Constants for Correlation Analysis in Chemistry and Biology; John Wiley: New York, 1979.
18. Selassie, C. D.; Klein, T. E. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 257-275.
19. Cattier-Humblet, C.; Carpy, A. Eur. J. Med. Chem.-Chim. Ther. 1985, 20, 251.
20. Carpy, A.; Leger, J. M.; Leclerc, J.; Dacker, N.; Ruot, B.; Vermuth, C. G. Mol. Pharmacol. 1982, 21, 400.
21. Sung, J. C.; Tropsha, A. J. Med. Chem. 1995, 38, 1060.
22. Brasili, L.; Pigini, M.; Bousquet, P.; Carotti, A.; Dontenwill, M.; Giannella, M.; Moriconi, R.; Piergentili, A.; Quaglia, W.; Tayebati, K. S. In Perspectives in Receptor Research; Giardin, D.; Piergentili, A.; Pigini, M., Eds.; Elsevier: Amsterdam, 1996; pp 361-373.
23. Nicklaus, M. C.; Wang, S.; Driscole, J. S.; Milne, G. W. A. Bioorg. Med. Chem. 1995, 4, 411.
24. Hariharan, S.; Shelver, H. W. Int. J. Quant. Chem. 1992, 44, 181.
25. Agarwal, A.; Pearson, P. P.; Taylor, E. W.; Li, H. B.; Dahlgren, T.; Herslof, M.; Yang, Y.; Lambert, G.; Nelson, D. L.; Regan, J. W.; Martin, A. R. J. Med. Chem. 1993, 36, 4006.
26. Hieble, J. P.; Bondinell, W. E.; Ruffolo, Jr, R. R. J. Med. Chem. 1995, 38, 3415 and 3681
27. Bylund, D. B. FASEB J. 1992, 6, 832.
28. Hoflack, J.; Trumpp-Kallmeyer, S.; Hubert, M. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 355-373.
29. Thibaut, U. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 661-696.
30. Carotti, A.; Altomare, C. La Chim. Ind. 1995, 77, 13.
31. Mattos, C.; Ringe, D. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 226-254.
32. Dabir, H.; Mouille, P.; Schmitt, H. Eur. J. Pharmacol. 1983, 86, 83.
33. Hansch, C.; Leo, A. QSAR Database. Biobyte Corp.: Claremont, CA, U.S.A.
34. van de Waterbeemd, H.; Testa, B. In Advances in Drug Research; Testa, B.; Ed.; Academic: New York, 1987; Vol. 16, pp 85-225.
35. MOPAC 6.0 is available from QCPE (506).
36. Clark, M.; Cramer.; R. D. Van Opdenbasch, N. J. Computat. Chem. 1989, 10, 982.
37. Ferguson, D. M.; Kolman, P. A. ibid 1991, 12, 620; and references therein.